{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:53:00Z","timestamp":1783151580396,"version":"3.54.6"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Monoclonal gammopathy of renal significance (MGRS) encompasses a heterogeneous group of kidney diseases in which a monoclonal immunoglobulin secreted by a clone of B cells or plasma cells causes kidney damage without meeting the hematological criteria for malignancy. Among the various forms of involvement, MGRS can manifest as a proximal tubule disorder, such as Fanconi syndrome (FS), characterized by urinary loss of phosphate, glucose, amino acids, uric acid and bicarbonate. Few cases of MGRS have been described in the literature, manifesting as FS and monoclonal production of lambda light chains, almost all of which are secondary to the production of kappa light chains.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Here we report a clinical case of a 45-year-old Brazilian male, African descent, with proximal weakness of the lower limbs, whose initial assessment showed a urine summary with the presence of proteinuria and glycosuria without hyperglycemia, associated with mild worsening of renal function, hypouricemia, hypocalcemia and phosphaturia. Evolution was characterized by a MGRS manifesting as FS and osteomalacia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The diagnosis of MGRS is not always easy, it requires knowledge of the clinical characteristics, diagnostic criteria and prognosis of each case. Therefore, all possible efforts should be made for multidisciplinary diagnosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-022-02901-9","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T12:03:19Z","timestamp":1660046599000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lambda light chain-induced monoclonal gammopathy of renal significance, manifesting with Fanconi Syndrome and osteomalacia"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4310-8754","authenticated-orcid":false,"given":"Gabriel Brayan","family":"Guti\u00e9rrez-Peredo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 C\u00e9sar Batista Oliveira","family":"Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Monta\u00f1o-Castell\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Jimena","family":"Guti\u00e9rrez-Peredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edvan\u00a0de Queiroz","family":"Cruso\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Gusmao-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"key":"2901_CR1","first-page":"473","volume":"4","author":"AP Enzo Pascali","year":"1989","unstructured":"Enzo Pascali AP. The clinical spectrum of pure bence Jones profeinuria. Am J Clin Pathol. 1989;4:473\u20135.","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"2901_CR2","first-page":"1","volume":"87","author":"F Bridoux","year":"2015","unstructured":"Bridoux F, Leung N, Hutchison CA, Touchard G, Sethi S, Fermand J, et al. Diagnosis of monoclonal gammopathy of renal significance. Int Soc Nephrol. 2015;87(4):1\u201314.","journal-title":"Int Soc Nephrol"},{"issue":"15","key":"2901_CR3","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1182\/bloodadvances.2019031914","volume":"3","author":"A Jain","year":"2019","unstructured":"Jain A, Haynes R, Kothari J, Khera A, Soares M, Ramasamy K. Pathophysiology and management of monoclonal gammopathy of renal signi fi cance. Blood Adv. 2019;3(15):2409\u201323.","journal-title":"Blood Adv"},{"key":"2901_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","volume":"15","author":"N Leung","year":"2019","unstructured":"Leung N, Bridoux F, Batuman V, AristeidisChaidos PC, D\u2019Agati VD, et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Ver Nephrol. 2019;15:45\u201359.","journal-title":"Nat Ver Nephrol"},{"issue":"22","key":"2901_CR5","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1182\/blood-2013-05-495929","volume":"122","author":"J Fermand","year":"2013","unstructured":"Fermand J, Bridoux F, Kyle RA, Kastritis E, Weiss BM, Cook MA, et al. How I Treat How I treat monoclonal gammopathy of renal signi fi cance (MGRS). Blood. 2013;122(22):3583\u201390.","journal-title":"Blood"},{"issue":"6","key":"2901_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0272-6386(98)70095-2","volume":"32","author":"KL Bate","year":"1998","unstructured":"Bate KL, Clouston D, Packham D, Ratnaike S, Ebeling PR. Lambda Light Chain Induced Nephropathy: A Rare Cause. Am J Kidney Dis. 1998;32(6):1\u20135.","journal-title":"Am J Kidney Dis"},{"key":"2901_CR7","first-page":"1","volume":"36","author":"H Tu","year":"2018","unstructured":"Tu H, Mou L, Zhu L, Jiang Q, Gao DS, Hu Y. Acquired Fanconi syndrome secondary to light chain deposition disease associated with monoclonal gammopathy of renal signi fi cance. Medicine (Baltimore). 2018;36:1\u20135.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"2901_CR8","first-page":"135","volume":"79","author":"T Messiaen","year":"2000","unstructured":"Messiaen T, Deret S, Mougenot B, Bridoux F, Dequiedt P, Dion JJ, Makdassi R, Meeus F, Pourrat J, Touchard G, Vanhille P, Zaoui P, Aucouturier P PMR. Adult Fanconi Syndrome Secundary to Light Chain Gammopathy. Clinicopathologic Heterogeneity and Unusual Features in 11 Patients. Med (United States). 2000;79(3):135\u201354.","journal-title":"Med (United States)"},{"issue":"35","key":"2901_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000183061","volume":"135","author":"N Alavi","year":"1983","unstructured":"Alavi N, Llanos EA, Palant CE, Bentzel CJ. Induction of Epithelial Tight Junctions by a Light Chain Protein Isolated from a Patient with Fanconi \u2019 s Syndrome. Nephron. 1983;135(35):130\u20135.","journal-title":"Nephron"},{"issue":"6","key":"2901_CR10","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S0889-8588(05)70126-X","volume":"13","author":"MQ Lacy","year":"1999","unstructured":"Lacy MQ, Gertz MA. Acquired Fanconi\u2019s Syndrome associated with monoclonal gammopathies. Hematol Oncol Clin North Am. 1999;13(6):1273\u201380.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"2901_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2003-10-3400","volume":"104","author":"CX Ma","year":"2016","unstructured":"Ma CX, Lacy MQ, Rompala JF, Dispenzieri A, Rajkumar SV, Greipp PR, et al. Brief report Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma. Blood. 2016;104(1):40\u20133.","journal-title":"Blood"},{"issue":"1","key":"2901_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/leu.2016.195","volume":"31","author":"M Vignon","year":"2017","unstructured":"Vignon M, Javaugue V, Alexander MP, El-Karoui K, Karras A, Roos-Weil D, et al. Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: A retrospective series of 49 patients. Leukemia. 2017;31(1):123\u20139.","journal-title":"Leukemia"},{"key":"2901_CR13","first-page":"6386","volume":"21","author":"C Heybeli","year":"2021","unstructured":"Heybeli C, Alexander MP, Bentall A, Amer H, Buadi F, Dean PG, et al. Kidney transplantation in patients with Monoclonal Gammopathy of Renal Significance (MGRS)-Associated Lesions: A case series. Am J Kidney Dis. 2021;21:6386\u2013692.","journal-title":"Am J Kidney Dis"},{"key":"2901_CR14","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1093\/ndt\/gfy259","volume":"34","author":"K Batko","year":"2019","unstructured":"Batko K, Malyszko J, Jurczyszyn A, Vesole DH, Gertz MA, Leleu X, et al. The clinical implication of monoclonal gammopathies\u202f: monoclonal gammopathy of undetermined significance and of renal significance. Nephrol Dial Transplant. 2019;34:1440\u201352.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2901_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12955-020-01464-3","volume":"18","author":"GB Guti\u00e9rrez-Peredo","year":"2020","unstructured":"Guti\u00e9rrez-Peredo GB, Martins MTS, Da Silva FA, Lopes MB, Lopes GB, Lopes AA. Functional dependence and the mental dimension of quality of life in Hemodialysis patients: The PROHEMO study. Health Qual Life Outcomes. 2020;18(1):1\u201310.","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"2901_CR16","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.nefro.2021.03.003","volume":"41","author":"GR Silva Novaes","year":"2021","unstructured":"Silva Novaes GR, Guti\u00e9rrez-Peredo GB, Monta\u00f1o-Castell\u00f3n I, Guti\u00e9rrez-Peredo AJ, Labanca J\u00fanior MN, Mattos Brand\u00e3o O, et al. Peritoneal dialysis in an adult patient with myelomenigocele and ventriculoperitoneal shunt. Nefrologia. 2021;41(6):708\u201310.","journal-title":"Nefrologia"},{"key":"2901_CR17","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s00432-012-1212-4","volume":"138","author":"W P\u00f6nisch","year":"2012","unstructured":"P\u00f6nisch W, Andrea M, Wagner I, Hammerschmidt D, Kreibich U, Schwarzer A, et al. Successful treatment of patients with newly diagnosed\/untreated multiple myeloma and advanced renal failure using bortezomib in combination with bendamustine and prednisone. J Cancer Res Clin Oncol. 2012;138:1405\u201312.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"2901_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4084\/mjhid.2019.007","volume":"11","author":"H Lee","year":"2019","unstructured":"Lee H, Duggan P, Neri P, Tay J, Jimenez-zepeda VH. Case Report: Bortezomib Maintenance for the Treatment of Monoclonal Gammopathy of Renal Significance. Mediterr J Hematol Infect Dis. 2019;11(1):2\u20136.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"2901_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1056\/NEJMoa2028631","volume":"385","author":"E Kastritis","year":"2021","unstructured":"Kastritis E, Palladini G, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, et al. Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis. N Engl J Med. 2021;385:46\u201358.","journal-title":"N Engl J Med"},{"key":"2901_CR20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2265.1995.tb02621.x","volume":"43","author":"BL Clarkets","year":"1995","unstructured":"Clarkets BL, Wynnetg AG, Wilson DM, Fitzpatrickt LA. Osteomalacia associated with adult Fanconi\u2019s syndrome: clinical and diagnostic features. Clin Endocronology. 1995;43:479\u201390.","journal-title":"Clin Endocronology"},{"issue":"25","key":"2901_CR21","first-page":"1351","volume":"292","author":"W Rawlings","year":"2010","unstructured":"Rawlings W, Griffin J, Duffy T, Humphrey R. Fanconi Syndrome with lambda light chains in urine. N Engl J Med. 2010;292(25):1351.","journal-title":"N Engl J Med"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02901-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-02901-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02901-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T12:05:10Z","timestamp":1660046710000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-02901-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2901"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-02901-9","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,9]]},"assertion":[{"value":"14 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Comit\u00ea de \u00c9tica do Hospital Universit\u00e1rio Professor Edgard Santos, Salvador, BA, Brazil. Certificate of Presentation for Ethical Consideration (CAAE): 36842220.4.0000.0049. Number of the Process: 4,261,644.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript was presented and approved by the Ethics and Research Committee of the Hospital Universitario Professor Edgar Santos de la Universidad Federal de Bah\u00eda with CAAE: 36842220.4.0000.0049 y dictamen 4.261.644. This study has the informed consent form duly applied and signed by the patient according to the rules of the ethics for the publication of their clinical data and images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None declared. The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"278"}}